Clinicians have long called for access to the data of the System for Monitoring Therapeutic Programs (SMPT), where they themselves enter information on completed tests and the course of treatment of patients treated under Drug Programs. Insight into this data means better evaluation of the effectiveness of therapy, the effectiveness of drug programs, and more precise planning of health measures.
On March 26 this year, the EU's European Data Space Regulation came into force, which introduces key changes in the way patients' medical information is processed, shared. This opens up new opportunities for scientific analysis.
Interactive report
At the end of March, clinicians including Prof. Ewa Lech-Marańda, Prof. Krzysztof Giannopoulos, representatives of the Institute for Health Protection and the Polish Society for Personalized Medicine sent a letter to Health Minister Izabela Leszczyna and Filip Nowak, president of the National Health Fund, requesting approval for the Interactive Report on the Most Important Indicators Describing the Treatment Process for Plasmacytoma Myeloma in Poland project.
The National Health Service has previously launched a website - a report - where data on AMD, the neovascular (exudative) form of age-related macular degeneration, is made available in a simple, graphical way. There is information on the most important indicators describing the treatment process. The values presented relate both to the most recent data and allow one to track trends over the past 36 months. All indicators and data - both nationwide and regional - are presented in the form of charts and tables, and you can easily compare them with each other or select only particular ones.
The Interactive Report on the Most Important Indicators Describing the Treatment Process for Plasmacytoma in Poland will be constructed along the lines of the AMD report. It will be freely available to patients, clinicians, officials and drug suppliers. All indicators and data - both nationwide and regional - will be presented in the form of charts and tables th...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
